Cytochrome P-450 metabolic-intermediate complex formation with a series of diphenhydramine analogues
- 28 Downloads
A series of diphenhydramine analogues have been studied with regard to their formation of a metabolic intermediate (MI) during their biotransformation in phenobarbital induced rat hepatic microsomes. The MI forms a complex with reduced cytochrome P-450. MI complexation of cytochrome P-450 may result in drug-drug interactions and/or in cumulation of the parent compound. The extent of MI complex formation could be correlated with the lipophilicity of the substrates in a parabolic manner. A hydrophobic pocket of limited dimensions in cytochrome P-450 for the N-alkyl substituent of the substrates can be assumed. Moreover our data indicate a role for the O-atom in the diphenhydramine analogues for the interaction with cytochrome P-450.
KeywordsComplex Formation Phenobarbital Parent Compound Diphenhydramine Hydrophobic Pocket
Unable to display preview. Download preview PDF.
- M. R. Franklin,Inhibition of mixed-function oxidations by substrates forming reduced cytochrome P-450 metabolic-intermediate complexes. Pharmacol. Ther. Part A3, 227–245 (1977).Google Scholar
- U. B. Paulsen-Sörman, K.-H. Jönssen and B. G. A. Lindeke,Cytochrome P-455 nm complex formation in the metabolism of phenylalkylamines 8. Stereoselectivity in metabolic intermediary complex formation with a series of chiral 2-substituted 1-phenyl-2-aminoethanes. J. Med. Chem.27, 342–346 (1984).PubMedGoogle Scholar
- A. Bast, F. A. A. van Kemenade, E. M. Savenije-Chapel and J. Noordhoek,Product inhibition in orphenadrine metabolism as a result of a stable cytochrome P-450-metabolic intermediate complex formed during the disposition of mono-N-desmethylorphenadrine (tofenacine) in the rat. Res. Commun. Chem. Pathol. Pharmacol.40, 391–403 (1983).PubMedGoogle Scholar
- R. F. Rekker and H. M. de Kort,The hydrophobic fragmental constant; an extension to a 1000 data point set. Eur. J. Med. Chem.14, 479–488 (1979).Google Scholar
- C. Hansch,quantitative relationships between lipophilic character and drug metabolism. Drug Metab. Rev.1, 1–13 (1972).Google Scholar